**Question:** Antiemetic action is produced through:

A. Anticholinergic action
B. Serotonin antagonism
C. Dopamine antagonism
D. Nerve stimulation

**Core Concept:** Antiemetics are medications that reduce or prevent nausea and vomiting. They act on specific neurotransmitter systems in the central nervous system, particularly the chemoreceptor trigger zone (CTZ) and the vomiting center (VC).

**Why the Correct Answer is Right:**
C. Dopamine antagonism is the correct answer as it explains the mode of action of the commonly used class of antiemetics known as dopamine antagonists, such as metoclopramide, ondansetron, and prochlorperazine. These drugs block the action of dopamine at the D2 receptor subtype, which is involved in the regulation of the CTZ and VC. By doing so, they suppress the vomiting reflex and prevent nausea and vomiting.

**Why Each Wrong Option is Incorrect:**
A. Anticholinergic action (A) is incorrect because anticholinergic medications, such as atropine, can increase nausea and vomiting by blocking the action of acetylcholine at muscarinic receptors, leading to dysmotility in the gastrointestinal tract and worsening of nausea and vomiting.

B. Serotonin antagonism (B) is partially correct but incomplete. Some antiemetics, like granisetron and palonosetron, work by blocking serotonin (5-HT3) receptors. However, the question specifically mentions dopamine antagonism as the core mechanism.

D. Nerve stimulation (D) is incorrect as the aim of antiemetics is to inhibit or reduce nausea and vomiting, not stimulate them. Nerve stimulation would lead to worsening of nausea and vomiting symptoms.

**Clinical Pearl:** Understanding the correct mode of action of antiemetics is essential for effective treatment of nausea and vomiting conditions like motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Choosing the right antiemetic based on the underlying cause of nausea and vomiting can significantly improve patient outcomes and reduce medication side effects.